Li, Zhi-Ming <br/><br/>
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.  [electronic resource] 

 -  PloS one  2012 
 - e41658 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0041658  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukocyte Count<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Middle Aged<br/>Monocytes--pathology<br/>Multivariate Analysis<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Proportional Hazards Models<br/>ROC Curve<br/>Risk Factors<br/>Rituximab<br/>Treatment Outcome<br/>Vincristine--therapeutic use